Pharmacokinetic boosting of olaparib: An open-label, prospective, cross-over study

被引：0
|
作者：
Overbeek, J. [1 ]
Guchelaar, N. [2 ]
Ali, M. I. Mohmaed [3 ,4 ]
Ottevanger, P. B.
Bloemendal, H. [5 ]
Koolen, S. [2 ]
Mathijssen, R. [2 ]
Boere, I. [6 ]
Hamberg, P. [6 ,7 ]
Huitema, A. [3 ,4 ]
Sonke, G. [8 ,9 ]
Opdam, F. [8 ,9 ]
Ter Heine, R. [1 ]
Van Erp, N. [1 ]
机构：
[1] Radboud Univ Nijmegen, Pharm, Med Ctr, Nijmegen, Netherlands
[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[4] Antoni Leeuwenhoek, Amsterdam, Netherlands
[5] Radboud Univ Nijmegen, Med Oncol Dept, Med Ctr, Nijmegen, Netherlands
[6] Erasmus Univ, Dept Med Oncol, Med Ctr, Rotterdam, Netherlands
[7] Franciscus Gasthuis & Vlietland, Med Oncol, Schiedam, Netherlands
[8] NKI Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] AVL Antoni Leeu wenhoek Hosp, Amsterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1948
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
769P
引用
收藏
页码：S522 / S522
页数：1
相关论文
共 50 条
  • [21] Comparative bioavailability of two formulations of terbinafine -: Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers
    Almeida, S
    Filipe, A
    Vallée, F
    Tanguay, M
    Larouche, R
    Lainesse, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (11): : 757 - 762
  • [22] Maraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot Study
    Krikke M.
    Tesselaar K.
    Arends J.E.
    Drylewicz J.
    Otto S.A.
    van Lelyveld S.F.L.
    Visseren F.J.L.
    Hoepelman A.I.M.
    Infectious Diseases and Therapy, 2016, 5 (3) : 389 - 404
  • [23] Pharmacokinetics and safety evaluation of oral Palonosetron in Chinese healthy volunteers: A phase 1, open-label, randomized, cross-over study
    Chen, Rui
    Wang, Hongyun
    Zhong, Wen
    Chessari, Salvatore
    Lanzarotti, Corinna
    Bernareggi, Alberto
    Hu, Pei
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 160
  • [24] Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects
    Luckey, Alison
    Alirol, Emilie
    Delhomme, Sophie
    O'Donnell, John
    Bettiol, Esther
    Mueller, John
    O'Brien, Seamus
    Gillon, Jean-Yves
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (05): : 770 - 780
  • [25] ISRADIPINE (ISR) IN THE TREATMENT OF HYPERTENSION IN RENAL-TRANSPLANT PATIENTS (RTP) ON CYCLOSPORINE (CSA) - A RANDOMIZED OPEN-LABEL CROSS-OVER STUDY
    BARRI, YM
    RAMOS, EL
    ORIG, J
    KARLIX, J
    PETERSON, JC
    PARRIS, CJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1072 - 1072
  • [26] Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers:: A cross-over, randomised, open-label study
    Brewster, M.
    Smith, J. R.
    Dutkowski, R.
    Robson, R.
    VACCINE, 2006, 24 (44-46) : 6660 - 6663
  • [27] Effectiveness of Recombinant Human Growth Hormone Therapy for Children With Phelan-McDermid Syndrome: An Open-Label, Cross-Over, Preliminary Study
    Li, TianXiao
    Xie, Ruijin
    Zhao, Jinling
    Xu, Hua
    Cui, Ying
    Sun, Chenyu
    Wang, Chunhong
    Liu, Yueying
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [28] Rituximab for refractory polymyositis: An open-label prospective study
    Mok, Chi Chiu
    Ho, Ling Yin
    To, Chi Hung
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (09) : 1864 - 1868
  • [29] A Randomised, Two-Period, Cross-Over, Open-Label Study to Evaluate the Pharmacokinetic Profiles of Single Doses of Two Different Flurbiprofen 8.75-mg Lozenges in Healthy Volunteers
    Matzneller, Peter
    Burian, Angela
    Martin, Wolfgang
    Annoni, Ottavia
    Lauro, Vittoria
    Tacchi, Raffaella
    Brunner, Martin
    Zeitlinger, Markus
    PHARMACOLOGY, 2012, 89 (3-4) : 188 - 191
  • [30] Rituximab for refractory polymyositis: An open-label prospective study
    Mok, C. C.
    Ho, L. Y.
    To, C. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 216 - 216
12345